PODD
Insulet CorporationStock · HealthcareS&P 500 Equal Weight 0.1% · Nasdaq Composite 0.02% · S&P 500 0.02% · Russell 1000 0.02% · Russell 3000 0.01% · US Stock Market 0.01% · MSCI ACWI 0.01% · MSCI World 0.01%$140.60-0.67%
as of market close, Sep 18, 2026
☾ AH — —
PODD — Insulet Corporation price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Volume
50.0100.0150.0200.0250.0300.0010.0M20.0M$140.60—20162019202120242026
2026-09-18
Price$140.60
MA20$158.35
MA50$238.19
Vol8.9M
Key stats
Price data
- Price
- $140.60
- Change YTD
- -50.53%
- Next earnings
- Nov 5, 2026
- Market cap
- 9.8B
- Enterprise value
- 10.2B
- Shares outstanding
- 69.4M
- 52W low
- $126.40
- 52W high
- $354.88
- From 52W high
- -60.38%
- From 52W low
- +11.23%
- 52W range
- 6%
- Beta
- 1.10
Volume
- Rel volume
- 1.49×
- 30D volume
- 1.7M
- 30D $ vol
- 241.1M
Fundamentals
- Sales (ttm)
- 3.1B
- Sales/share
- $44.03
- EPS (ttm)
- $5.34
- FCF (ttm)
- 293.7M
- FCF/share
- $4.23
- Book value/share
- $20.51
- Net margin
- 12.29%
- ROE
- 26.39%
- ROA
- 11.86%
- Debt / equity
- 0.65×
- Current ratio
- 2.48
Growth (CAGR, ttm) · 10Y
- Sales
- +29.44%+27.73%+25.28%+25.16%
- Net income
- +59.01%+81.35%n/an/a
- FCF
- -27.48%+113.41%n/an/a
- Shares
- -1.48%-0.22%+0.14%+1.93%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +65.72%+81.42%n/an/a
- Sales/share
- +31.38%+28.01%+25.11%+22.79%
- FCF/share
- -26.39%+113.89%n/an/a
- Book value/share
- -1.33%+37.23%+25.20%+45.60%
- Price
- -57.87%-6.31%-13.62%+12.71%
- Total return
- -57.87%-6.31%-13.62%+12.71%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 26.3×
- P/OI (ttm)
- 18.9×
- Fwd P/E
- 17.9×
- P/S (ttm)
- 3.2×
- P/B (mrq)
- 6.9×
- P/FCF (ttm)
- 33.2×
- EV/EBITDA (fy)
- 16.6×
- EV/Sales (ttm)
- 3.3×
- FCF yield (ttm)
- 3.01%
- Buyback yield (realized, 1y)
- 1.48%
- Shareholder yield (realized, 1y)
- 1.48%
- Buyback yield (cash, ttm)
- 3.38%
- Shareholder yield (cash, ttm)
- 3.38%
Vs own 10Y history
- P/E
- 1st
- P/OI
- 0th
- P/S
- 0th
- P/B
- 0th
- P/FCF
- 7th
Bar = where today’s multiple sits in PODD’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-09-18
1D
-0.67%
5D
+6.55%
1M
-5.02%
3M
-3.54%
YTD
-50.53%
1Y
-57.84%
5Y
-51.92%
Financial statements
Open full PODD financials →Loading financial statements…
Related Healthcare
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | -5.94% | +0.04% |
| JNJ | Johnson & Johnson | -0.41% | -0.09% |
| ABBV | AbbVie Inc. | +1.95% | -0.02% |
| MRK | Merck & Co. Inc. | +8.66% | -0.19% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | -4.32% | +0.45% |
| TMO | Thermo Fisher Scientific Inc. | +10.60% | -1.04% |
| AMGN | Amgen Inc. | -9.32% | +1.55% |
| GILD | Gilead Sciences Inc. | +4.65% | -0.52% |
Insulet Corporation (PODD) trades at $140.60 with a live price and an interactive chart covering 19+ years of daily price history, plus key valuation metrics. ChartRow also publishes PODD’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full PODD financial statements →
